The Ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer
10.1158/0008-5472.CAN-04-1207
Saved in:
Main Authors: | Lo, T.L., Yusoff, P., Fong, C.W., McCaw, B.J., Wong, E.S.M., Leong, H.F., Guy, G.R., Guo, K., Zeng, Q., Putti, T.C., Yang, H., Phillips, W.A. |
---|---|
Other Authors: | PATHOLOGY |
Format: | Article |
Published: |
2012
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/30345 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
by: Fong, C.W., et al.
Published: (2014) -
The cysteine-rich sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phosphatidylinositol 4,5-bisphosphate in plasma membranes
by: Lim, J., et al.
Published: (2014) -
Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf
by: Yusoff, P., et al.
Published: (2014) -
Evidence for Direct Interaction between Sprouty and Cbl
by: Wong, E.S.M., et al.
Published: (2014) -
Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling
by: Wong, E.S.M., et al.
Published: (2014)